Get started
Work

New method for immunoprofiling of the tumor microenvironment of cancer patients by opal multiplex quantitative immunofluorescence (IF) assay

Year: 2015
Type: article
Abstract: Meeting abstracts Bavituximab is a novel chimeric IgG1 monoclonal antibody targeting the membrane phospholipid, phosphatidylserine (PS), externalized on the luminal surface of endothelium in tumors, tumor cells, and tumor exosomes under stressor conditions in the tumor microenvironment. PS exposure
DOI: 10.1186/2051-1426-3-s2-p94
Authors: Nikoletta L Kallinteris, Joseph Shan, Jeffrey Meyer, Adam C Yopp, Athur Frankel, Sean R Downing, Brenda S Robertson, Cliff Hoyt, Steven King, Carlo Bifulco, Carmen Ballesteros-Merino, Bernard Fox
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W2246747525
FWCI:
Cites:
Cited by:
Related to: 10